Nuveen Asset Management, LLC Cerus Corp Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cerus Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 462,550 shares of CERS stock, worth $777,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares
462,550
Previous 462,550 -0.0%
Holding current value
$777,084
Previous $804,000 11.44%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$1.62 - $2.04 $29,015 - $36,538
17,911 Added 4.03%
462,550 $814,000
Q4 2023

Feb 14, 2024
SELL
$1.25 - $2.35 $1.26 Million - $2.38 Million
-1,011,105 Reduced 69.46%
444,639 $960,000
Q3 2023

Nov 14, 2023
BUY
$1.5 - $3.07 $192,712 - $394,418
128,475 Added 9.68%
1,455,744 $2.36 Million
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.9 $194,592 - $315,261
108,711 Added 8.92%
1,327,269 $3.27 Million
Q1 2023

May 15, 2023
BUY
$2.65 - $3.81 $665 - $956
251 Added 0.02%
1,218,558 $3.62 Million
Q4 2022

Feb 14, 2023
BUY
$3.38 - $4.22 $575,924 - $719,054
170,392 Added 16.26%
1,218,307 $4.45 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $44,802 - $76,151
13,062 Added 1.26%
1,047,915 $3.77 Million
Q2 2022

Aug 15, 2022
BUY
$4.41 - $5.69 $44,311 - $57,173
10,048 Added 0.98%
1,034,853 $5.48 Million
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $29,663 - $43,107
6,167 Added 0.61%
1,024,805 $5.56 Million
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $272,094 - $361,425
-45,577 Reduced 4.28%
1,018,638 $6.29 Million
Q3 2021

Nov 12, 2021
SELL
$4.79 - $6.68 $95,550 - $133,252
-19,948 Reduced 1.84%
1,064,215 $7.09 Million
Q2 2021

Aug 16, 2021
SELL
$5.35 - $6.35 $208,173 - $247,084
-38,911 Reduced 3.46%
1,084,163 $6.41 Million
Q1 2021

May 17, 2021
SELL
$5.68 - $7.87 $111,186 - $154,055
-19,575 Reduced 1.71%
1,123,074 $6.75 Million
Q4 2020

Feb 16, 2021
SELL
$5.25 - $8.56 $99,009 - $161,433
-18,859 Reduced 1.62%
1,142,649 $7.91 Million
Q3 2020

Nov 16, 2020
SELL
$5.78 - $7.47 $1.11 Million - $1.43 Million
-191,862 Reduced 14.18%
1,161,508 $7.27 Million
Q2 2020

Aug 14, 2020
BUY
$4.5 - $7.02 $706,599 - $1.1 Million
157,022 Added 13.13%
1,353,370 $8.93 Million
Q1 2020

May 14, 2020
BUY
$2.87 - $5.49 $872,646 - $1.67 Million
304,058 Added 34.08%
1,196,348 $5.56 Million
Q4 2019

Feb 14, 2020
BUY
$3.84 - $4.86 $890,300 - $1.13 Million
231,849 Added 35.11%
892,290 $3.77 Million
Q3 2019

Nov 14, 2019
BUY
$4.86 - $6.05 $71,184 - $88,614
14,647 Added 2.27%
660,441 $3.41 Million
Q2 2019

Aug 15, 2019
BUY
$4.51 - $6.6 $2.91 Million - $4.26 Million
645,794 New
645,794 $3.63 Million

Others Institutions Holding CERS

# of Institutions
165
Shares Held
140M
Call Options Held
100K
Put Options Held
16K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $298M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email